Tango Therapeutics | 4:持股變動聲明-股東 EcoR1 Capital, LLC
Tango Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-BCTG Holdings, LLC(6.5%),Aaron I. Davis(3.5%)等
Tango Therapeutics | 4:持股變動聲明- Boxer Capital Management, LLC
Tango Therapeutics | 144:擬議出售證券
Tango Therapeutics | 10-Q:2024財年三季報
Tango Therapeutics | 8-K:Tango Therapeutics公佈2024年第三季度財務業績並提供業務亮點
Tango Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-BCTG Holdings, LLC(6.5%),Aaron I. Davis(6.4%)等
Tango Therapeutics | 4:持股變動聲明- Boxer Capital Management, LLC
Tango Therapeutics | 144:擬議出售證券
Tango Therapeutics | 4:持股變動聲明- Boxer Capital Management, LLC
Tango Therapeutics | 144:擬議出售證券
Tango Therapeutics | 3:首次持股聲明- Boxer Capital Management, LLC
Tango Therapeutics | 144:擬議出售證券
Tango Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Aaron I. Davis(7.8%),Boxer Capital Management, LLC(7.6%)等
Tango Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Braslyn Ltd.(Less than 0.1%),Joe Lewis(Less than 0.1%)等
Tango Therapeutics | 4:持股變動聲明-股東 Third Rock Ventures IV, L.P.
Tango Therapeutics | 144:擬議出售證券
Tango Therapeutics | 4:持股變動聲明-股東 Third Rock Ventures IV, L.P.
Tango Therapeutics | 4:持股變動聲明- Davis Aaron I.
Tango Therapeutics | 144:擬議出售證券
暫無數據
暫無數據